What is Caerus?
Caerus Corp is a prominent medical technology firm specializing in the design, development, and manufacturing of advanced pain relief and orthopedic bracing technologies. Operating through four distinct business units, the company caters to specific market segments, offering patient-centered solutions for both human and animal applications. Its product portfolio includes well-regarded brands such as OrthoCor Medical and Animal Ortho Care. All products are manufactured at their ISO 13485 certified and FDA registered facility located in Blaine, Minnesota, ensuring adherence to the highest quality and safety standards within the medical device industry.
How much funding has Caerus raised?
Caerus has raised a total of $2.9M across 2 funding rounds:
Private Equity
$2.5M
Debt
$350K
Private Equity (2016): $2.5M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in Caerus
PPP
Public-Private Partnership
What's next for Caerus?
The recent major strategic investment signifies a critical growth phase for Caerus, likely enabling the company to scale its operations, expand its market reach, and further invest in research and development for its innovative orthopedic and pain relief technologies. This capital infusion is expected to accelerate the company's trajectory, potentially leading to broader adoption of its patient-centered solutions across both human and animal health sectors. The company's commitment to quality, evidenced by its ISO 13485 certification and FDA registration, positions it favorably for continued expansion and market leadership.
See full Caerus company page
